These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16735756)

  • 1. Estimating binding affinities of the nicotinic receptor for low-efficacy ligands using mixtures of agonists and two-dimensional concentration-response relationships.
    Purohit Y; Grosman C
    J Gen Physiol; 2006 Jun; 127(6):719-35. PubMed ID: 16735756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-Response Analysis When There Is a Correlation between Affinity and Efficacy.
    Auerbach A
    Mol Pharmacol; 2016 Feb; 89(2):297-302. PubMed ID: 26655305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling differential binding of alpha4beta2 nicotinic acetylcholine receptor with agonists and antagonists.
    Huang X; Zheng F; Zhan CG
    J Am Chem Soc; 2008 Dec; 130(49):16691-6. PubMed ID: 19554732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dissociation of acetylcholine from open nicotinic receptor channels.
    Grosman C; Auerbach A
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):14102-7. PubMed ID: 11717464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site.
    Akk G; Steinbach JH
    J Neurosci; 2005 Feb; 25(8):1992-2001. PubMed ID: 15728839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling multiple species of nicotine and deschloroepibatidine interacting with alpha4beta2 nicotinic acetylcholine receptor: from microscopic binding to phenomenological binding affinity.
    Huang X; Zheng F; Crooks PA; Dwoskin LP; Zhan CG
    J Am Chem Soc; 2005 Oct; 127(41):14401-14. PubMed ID: 16218635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional equivalence of the nicotinic acetylcholine receptor transmitter binding sites in the open state.
    Tantama M; Licht S
    Biochim Biophys Acta; 2009 May; 1788(5):936-44. PubMed ID: 19366595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of heteroliganded mouse muscle nicotinic receptors.
    Akk G; Milescu LS; Heckmann M
    J Physiol; 2005 Apr; 564(Pt 2):359-76. PubMed ID: 15718267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inorganic, monovalent cations compete with agonists for the transmitter binding site of nicotinic acetylcholine receptors.
    Akk G; Auerbach A
    Biophys J; 1996 Jun; 70(6):2652-8. PubMed ID: 8744302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctions in agonist and antagonist specificity conferred by anionic residues of the nicotinic acetylcholine receptor.
    Osaka H; Sugiyama N; Taylor P
    J Biol Chem; 1998 May; 273(21):12758-65. PubMed ID: 9582301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chain length dependence of the interactions of bisquaternary ligands with the Torpedo nicotinic acetylcholine receptor.
    Carter CR; Cao L; Kawai H; Smith PA; Dryden WF; Raftery MA; Dunn SM
    Biochem Pharmacol; 2007 Feb; 73(3):417-26. PubMed ID: 17118342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists.
    Jonnala RR; Buccafusco JJ
    J Neurosci Res; 2001 Nov; 66(4):565-72. PubMed ID: 11746376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and block of mouse muscle-type nicotinic receptors by tetraethylammonium.
    Akk G; Steinbach JH
    J Physiol; 2003 Aug; 551(Pt 1):155-68. PubMed ID: 12824448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mechanism of inhibition of the nicotinic acetylcholine receptor by the anticonvulsant MK-801 investigated by laser-pulse photolysis in the microsecond-to-millisecond time region.
    Grewer C; Hess GP
    Biochemistry; 1999 Jun; 38(24):7837-46. PubMed ID: 10387024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site specificity of agonist-induced opening and desensitization of the Torpedo californica nicotinic acetylcholine receptor.
    Andreeva IE; Nirthanan S; Cohen JB; Pedersen SE
    Biochemistry; 2006 Jan; 45(1):195-204. PubMed ID: 16388595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoflurane increases the apparent agonist affinity of the nicotinic acetylcholine receptor by reducing the microscopic agonist dissociation constant.
    Raines DE; Zachariah VT
    Anesthesiology; 2000 Mar; 92(3):775-85. PubMed ID: 10719956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of muscle nicotinic acetylcholine receptor channels by nicotinic and muscarinic agonists.
    Akk G; Auerbach A
    Br J Pharmacol; 1999 Dec; 128(7):1467-76. PubMed ID: 10602325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of nondepolarizing neuromuscular blocking drugs to act as partial agonists at fetal and adult mouse muscle nicotinic receptors.
    Fletcher GH; Steinbach JH
    Mol Pharmacol; 1996 May; 49(5):938-47. PubMed ID: 8622644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential pharmacological activity of JN403 between α7 and muscle nicotinic acetylcholine receptors.
    Arias HR; De Rosa MJ; Bergé I; Feuerbach D; Bouzat C
    Biochemistry; 2013 Nov; 52(47):8480-8. PubMed ID: 24164482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor.
    Arias HR
    Arch Biochem Biophys; 1996 Sep; 333(1):1-11. PubMed ID: 8806747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.